1Analysis of the evolution of drug registration and management policies in China from the perspective of policy toolsZHU Jun-cheng, WANG Shu-ling449-4562Comparison of equal value of life years gained and quality-adjusted life-year as health outcome measuresHU Zhao, LIU Yong-jun457-4643New quality productivity empowers the high-quality development of the pharmaceutical industry:theoretical logic and practical pathSUN Qi, LI Yong465-4724Introduction to the system model of U.S.FDA warning lettersHE Hui, ZHOU Gang473-4765Advancements in pharmaceutical co-crystal research and key considerationsPAN Jing, HUANG Xiao-long477-4826Advances in protein kinase B inhibitor capivasertib for breast cancer treatmentGENG Ji-hong, QUAN Xiang-hua, ZHAO Jun, DU Cai-ying, SUN Cai-hong, YUAN Hai-dan483-4897Ensartinib treatment for REV1-ALK/EML4-ALK complex ALK fusion lung adenocarcinoma:a case reportZHANG Chang-gong490-4938Clinical significance of serum levels of total cholesterol,high-density lipoprotein and lipoprotein(a)in the prognosis of colorectal cancerPAN Ru-yan, WANG Yue, ZHU Qi, LU Yi, XIAO Yao494-4979Analysis of civil liability and risk response to adverse event disputes in drug clinical trialsZHAO Tian-jiao, DENG Yong498-50410Discussion on the rights of subjects after termination of clinical trials for anticancer drugsYANG Feng, YANG Wan-shuang, GONG Qian505-51011Tianhuang formula enhancing nonalcoholic fatty liver disease in mice through regulating gut microbiotaLUO Zhi-zhong, YANG Ling, HAN Yi, GUO Jiao, LUO Duo-sheng511-52112Study on the moulding process and quality standard of classical prescription of Yihuang decoction granules based on mixture designLU Fang-qi, YU Ling-jing, CHEN Nuo, LIU Yi-peng, WU Wei, WU Cheng-chao, ZHONG Shao-hui, LU Li-rong, HUANG Shi-wen, CHENG Jian-ming522-53013Research on the quality standard of Bushen Guquan GranulesLI Wen-jie, TIAN Wen-xiu, XUE Ai-le, ZHENG Min-yue, ZHANG Lei, WANG You-jie, HONG Yan-long531-54014Study on N-nitrosamine impurities in dipine drugsWU Zhong-li, ZHENG Guo-gang, JIA Fei, LI Chen, ZHOU Jian, YU Cheng-xiong, GAO Ying, WANG Bo, LOU Jin-fang541-55215Literature analysis of adverse drug reactions induced by pazopanibZHANG Xiao-xin, WU Ming-ming, RUAN Xian-mei553-560 